Land: Irland
Språk: engelsk
Kilde: HPRA (Health Products Regulatory Authority)
OMEGA-3-ACID ETHYL ESTERS, EICOSAPENTAENOIC ACID, DOCOSAHEXANOIC ACID
Imbat Limited
C10AX06
OMEGA-3-ACID ETHYL ESTERS, EICOSAPENTAENOIC ACID, DOCOSAHEXANOIC ACID
1000 Milligram
Capsules, Soft
Product subject to prescription which may be renewed (B)
Other lipid modifying agents
Authorised
2010-06-18
Page 1 of 2 PACKAGE LEAFLET: INFORMATION FOR THE USER OMACOR ® 1000MG SOFT CAPSULES (omega-3-acid ethyl esters 90) Your medicine is available using the above name but will be referred to as Omacor throughout this leaflet. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. Keep this leaflet. You may want to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Omacor is and what it is used for 2. Before you take Omacor 3. How to take Omacor 4. Possible side effects 5. How to store Omacor 6. Contents of the pack and other information 1. WHAT OMACOR IS AND WHAT IT IS USED FOR Omacor contains highly purified omega-3 polyunsaturated fatty acids. Omacor belongs to a group of so called reducers of cholesterol and triglycerides. Omacor is used: together with other medicines for treatment after a heart attack. to treat certain forms of increased triglycerides (fats) in the blood after changes to the diet have not worked. 2. BEFORE YOU TAKE OMACOR DO NOT TAKE OMACOR, IF you are allergic (hypersensitive) to the main ingredient or any of the other ingredients of Omacor (see Section: Important information about some of the ingredients, and Section 6: Contents of the pack and other information). If any of the above applies to you, do not take this medicine, and talk to your doctor. read_full_document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Omacor 1000mg Soft Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Omega-3-acid ethyl esters 90 1000 mg Comprising 840 mg eicosapentaenoic acid (EPA) ethyl ester (460mg) and docosahexaenoic acid (DHA) ethyl ester (380mg) for one capsule Excipients: may contain soya bean oil For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Capsule, soft _Product imported from the UK:_ Soft, oblong, transparent gelatin capsules containing pale yellow oil 4 CLINICAL PARTICULARS As per PA1099/001/001. 5 PHARMACOLOGICAL PROPERTIES As per PA1099/001/001. 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS alpha-tocopherol gelatin glycerol purified water medium-chain triglycerides lecithin (soya) 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf life expiry date of this product is the date shown on the container and outer carton of the product as marketed in the country of origin. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 28/11/2014_ _CRN 2149210_ _page number: 1_ 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25°C. Do not freeze. 6.5 NATURE AND CONTENTS OF CONTAINER White plastic container in a cardboard carton. Pack size: 28 Capsules. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER Imbat Limited Unit L2 North Ring Business Park Santry Dublin 9 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA1151/134/001 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 18th June 2010 10 DATE OF REVISION OF THE TEXT November read_full_document